![Jeff Baxter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Baxter
Director Ejecutivo en
VBI Vaccines (Delaware), Inc.
.
Perfil
El Sr. Jeffrey R. Baxter es Presidente, Consejero Delegado y Director de VBI Vaccines, Inc., Director Independiente no Ejecutivo de Chromadex Corp., Presidente, Consejero Delegado y Director de VBI Vaccines (Delaware), Inc. y Presidente, Consejero Delegado y Director de Variation Biotechnologies (US), Inc. Es miembro del Consejo de Administración de VBI Vaccines, Inc., Chromadex Corp. y VBI Vaccines (Delaware), Inc. y Variation Biotechnologies (US), Inc. Anteriormente, el Sr. Baxter trabajó como vicepresidente senior de finanzas, operaciones, investigación y desarrollo en GlaxoSmithKline Plc, como director en British American Tobacco plc, como socio gerente en The Column Group LLC y como director en Unilever Plc. Se licenció en la Universidad de Thames Valley.
Cargos activos de Jeff Baxter
| Empresas | Cargo | Inicio |
|---|---|---|
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Presidente | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Director Ejecutivo | 01/07/2014 |
Antiguos cargos conocidos de Jeff Baxter.
| Empresas | Cargo | Fin |
|---|---|---|
| VBI VACCINES INC. | Director Ejecutivo | 03/01/2025 |
| NIAGEN BIOSCIENCE, INC. | Director/Miembro de la Junta | 04/04/2022 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Director de Inversiones | 28/02/2009 |
| GSK PLC | Corporate Officer/Principal | 01/07/2006 |
| UNILEVER PLC | Corporate Officer/Principal | - |
Formación de Jeff Baxter.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
56
Relaciones de 1er grado
9
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
British American Tobacco plc
 British American Tobacco plc TobaccoConsumer Non-Durables Manufactures and supplies tobacco products | Consumer Non-Durables |
Unilever Plc
 Unilever Plc Household/Personal CareConsumer Non-Durables Provides fast moving consumer goods | Consumer Non-Durables |
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Develops and manufactures vaccines for infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Chromadex Corp.
 Chromadex Corp. Pharmaceuticals: OtherHealth Technology Acquires, develops and commercializes proprietary-based ingredient technologies | Health Technology |
University of West London
 University of West London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VBI Vaccines, Inc.
 VBI Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
- Bolsa de valores
- Insiders
- Jeff Baxter
